Literature DB >> 19782076

A scanning peptide array approach uncovers association sites within the JNK/beta arrestin signalling complex.

Xiang Li1, Ruth MacLeod, Allan J Dunlop, Helen V Edwards, Noopur Advant, Lucien C D Gibson, Nicola M Devine, Kim M Brown, David R Adams, Miles D Houslay, George S Baillie.   

Abstract

Beta arrestins are molecular scaffolds that can bring together three-component mitogen-activated protein kinase signalling modules to promote signal compartmentalisation. We use peptide array technology to define novel interfaces between components within the c-Jun N-terminal kinase (JNK)/beta arrestin signalling complex. We show that beta arrestin 1 and beta arrestin 2 associate with JNK3 via the kinase N-terminal domain in a region that, surprisingly, does not harbour a known 'common docking' motif. In the N-domain and C-terminus of beta arrestin 1 and beta arrestin 2 we identify two novel apoptosis signal-regulating kinase 1 binding sites and in the N-domain of the beta arrestin 1 and beta arrestin 2 we identify a novel MKK4 docking site.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19782076     DOI: 10.1016/j.febslet.2009.09.035

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Arrestin-3 interaction with maternal embryonic leucine-zipper kinase.

Authors:  Nicole A Perry; Kevin P Fialkowski; Tamer S Kaoud; Ali I Kaya; Andrew L Chen; Juliana M Taliaferro; Vsevolod V Gurevich; Kevin N Dalby; T M Iverson
Journal:  Cell Signal       Date:  2019-07-25       Impact factor: 4.315

2.  A single mutation in arrestin-2 prevents ERK1/2 activation by reducing c-Raf1 binding.

Authors:  Sergio Coffa; Maya Breitman; Benjamin W Spiller; Vsevolod V Gurevich
Journal:  Biochemistry       Date:  2011-07-13       Impact factor: 3.162

Review 3.  JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships.

Authors:  András Zeke; Mariya Misheva; Attila Reményi; Marie A Bogoyevitch
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-27       Impact factor: 11.056

4.  Arrestin-3 binds the MAP kinase JNK3α2 via multiple sites on both domains.

Authors:  Xuanzhi Zhan; Alejandro Perez; Luis E Gimenez; Sergey A Vishnivetskiy; Vsevolod V Gurevich
Journal:  Cell Signal       Date:  2014-01-08       Impact factor: 4.315

5.  β-Arrestin 1 inhibits the GTPase-activating protein function of ARHGAP21, promoting activation of RhoA following angiotensin II type 1A receptor stimulation.

Authors:  D F Anthony; Y Y Sin; S Vadrevu; N Advant; J P Day; A M Byrne; M J Lynch; G Milligan; M D Houslay; G S Baillie
Journal:  Mol Cell Biol       Date:  2010-12-20       Impact factor: 4.272

Review 6.  Custom-designed proteins as novel therapeutic tools? The case of arrestins.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Expert Rev Mol Med       Date:  2010-04-23       Impact factor: 5.600

7.  The structure of the human RNase H2 complex defines key interaction interfaces relevant to enzyme function and human disease.

Authors:  Martin A M Reijns; Doryen Bubeck; Lucien C D Gibson; Stephen C Graham; George S Baillie; E Yvonne Jones; Andrew P Jackson
Journal:  J Biol Chem       Date:  2010-12-22       Impact factor: 5.157

8.  Small peptide inhibitor of JNK3 protects dopaminergic neurons from MPTP induced injury via inhibiting the ASK1-JNK3 signaling pathway.

Authors:  Jing Pan; Hui Li; Bei Zhang; Ran Xiong; Yu Zhang; Wen-Yan Kang; Wei Chen; Zong-Bo Zhao; Sheng-Di Chen
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

9.  C-Jun N-terminal kinase (JNK) isoforms play differing roles in otitis media.

Authors:  William Yao; Meredith Frie; Jeffrey Pan; Kwang Pak; Nicholas Webster; Stephen I Wasserman; Allen F Ryan
Journal:  BMC Immunol       Date:  2014-10-14       Impact factor: 3.615

Review 10.  Multifaceted role of β-arrestins in inflammation and disease.

Authors:  D Sharma; N Parameswaran
Journal:  Genes Immun       Date:  2015-09-17       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.